Donato currently leads the Cannabis investment banking team at Eight Capital, as Principal and Managing Director. He has significant capital markets experience on both buy and sell sides.
The team has raised the most capital in the Cannabis space, with lead positions in both private and public company financings. Donato has advised on the only two major transactions in the space, most recently advising Canopy Growth Corp. on the $430MM acquisition of Mettrum and prior to that, advising Bedrocan on the sale to Tweed. In the past six months, Eight Capital has led the $15MM raise for Cronos Group, $35MM raise for Emerald Health, $33.5MM raise for MariCann, $60MM raise for Canopy, $40MM raise for Organigram, as well as many others.
Donato has 6 years as an institutional equity salesperson at Dundee and a large Global Investment Bank. He previously worked at a Canadian bank owned dealer and at a big four accounting firm in the advisory practice. Experience includes working as an Industrials, Auto Parts and Special Situations Research Analyst at a bank owned dealer and as Vice President of Investments at a small cap focused buy side firm in Toronto.